Clik here to view.
Guthrie Introduces Xenex Germ-Zapping Robots to Sanitize Operating Rooms
Friday, March 11th 2016 at 5:23pm UTC SAYRE, Pa.–(BUSINESS WIRE)– Guthrie announced today the arrival of special robots that use pulsed xenon light technology to disinfect its Operating Rooms. Guthrie...
View ArticleClik here to view.
Medicrea® Celebrates 500 UNID Surgeries and Launches Real-Time Support for...
Friday, March 11th 2016 at 5:00pm UTC UNiDTM Lab Services Collaborate with Spine Surgeons for Pre-operative Planning, Order Fulfillment and Post-Operative Analysis; MEDICREA Achieves More Than 500...
View ArticleClik here to view.
Concentric Health Experience and Scientific Global Communications Announce...
Monday, March 14th 2016 at 2:28pm UTC Agencies to provide healthcare brands strategic alignment between promotion and medical communications NEW YORK–(BUSINESS WIRE)– Concentric Health Experience, an...
View ArticleClik here to view.
Flatiron Health and Via Oncology Announce Availability of Via Pathways for...
Tuesday, March 15th 2016 at 11:30am UTC NEW YORK–(BUSINESS WIRE)– Flatiron Health and Via Oncology announced today that Via Pathways for breast, colon, rectal, non-small cell and small-cell lung,...
View ArticleClik here to view.
Bristol-Myers Squibb to Announce Results for First Quarter 2016 on April 28
Tuesday, March 15th 2016 at 3:00pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the first quarter of 2016 on Thursday, April 28, 2016. During a...
View ArticleClik here to view.
Remedy Pharmaceuticals Appoints Thomas MacAllister as Vice President of...
Tuesday, March 15th 2016 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– Remedy Pharmaceuticals, a privately-held, Phase 3-ready pharmaceutical company focused on bringing life-saving hospital-based treatment...
View ArticleClik here to view.
Cellectis Reports Fourth Quarter and Full Year 2015 Financial Results
Monday, March 14th 2016 at 9:19pm UTC – On track with submission of UCART19 Clinical Trial Application; Application Filed with MHRA (UK) – Encouraging data from the First-in-Human compassionate use of...
View ArticleClik here to view.
SIGA Technologies Engages PiperJaffray as Financial Advisor
Tuesday, March 15th 2016 at 8:45pm UTC NEW YORK–(BUSINESS WIRE)– SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGAQ), a company specializing in the commercialization of solutions for serious unmet medical...
View ArticleClik here to view.
Cellectis and MabQuest Announce Immunotherapy Partnership on New Class of...
Wednesday, March 16th 2016 at 9:00pm UTC NEW YORK & PULLY, Switzerland–(BUSINESS WIRE)– class= »bwalignl »> Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS – Nasdaq:...
View ArticleClik here to view.
Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory...
Wednesday, March 16th 2016 at 12:00pm UTC Seven Abstracts, Including Pivotal Phase 3 Data in Ulcerative Colitis, Accepted for Presentation NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) announced...
View ArticleClik here to view.
ProEd Launches Global Market Access Practice
Thursday, March 17th 2016 at 12:43pm UTC Industry Expert Scott Roberts Returns to ProEd to Lead New Group NEW YORK–(BUSINESS WIRE)– ProEd Communications, Inc., a member of the Healthcare Consultancy...
View ArticleClik here to view.
SIGA Commences Clinical Study for Intravenous (IV) Formulation of TPOXX
Thursday, March 17th 2016 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGAQ), a company specializing in the development and commercialization of solutions for...
View ArticleClik here to view.
Osiris Therapeutics to Present at the 4th Annual Cell and Gene Therapy...
Friday, March 18th 2016 at 1:30pm UTC COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing...
View ArticleClik here to view.
Onxeo Announces Establishment of U.S. Subsidiary
Monday, March 21st 2016 at 7:00am UTC Pharmaceutical and biotech industry veteran, Philippe Maitre, to head U.S subsidiary PARIS & COPENHAGEN, Denmark–(BUSINESS WIRE)– class= »bwalignl »>...
View ArticleClik here to view.
Synergy Pharmaceuticals’ Exchange Agreements to Reduce 50% of Senior Notes...
Monday, March 21st 2016 at 10:00am UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that the exchange agreements entered into on March 17, 2016, with certain...
View ArticleClik here to view.
Acorda Wins Federal Circuit Appeal Allowing AMPYRA® Patent Litigation to...
Monday, March 21st 2016 at 11:30am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that the United States Court of Appeals for the Federal Circuit has upheld...
View ArticleClik here to view.
Cellectis Announces RetroNectin® Supply and License Agreement with Takara Bio...
Monday, March 21st 2016 at 9:00pm UTC NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS – Nasdaq Global Market: CLLS), a biopharmaceutical company...
View ArticleClik here to view.
Syntimmune Secures Second Tranche of $26 Million Series A Financing
Tuesday, March 22nd 2016 at 11:30am UTC IND application for lead SYNT001 program expected in mid-2016; Company fully capitalized through achievement of clinical proof-of-concept in IgG-mediated...
View ArticleClik here to view.
CBD Scientific Breakthrough Increases Bioavailability in Water Soluble Version
Tuesday, March 22nd 2016 at 11:10am UTC NEW YORK–(BUSINESS WIRE)– The International Cannabidiol Organization of Manufacturers and Research (ICOMR.ORG) jointly announce a scientific breakthrough with...
View ArticleClik here to view.
Heidi Levine Joins Sidley in New York
Tuesday, March 22nd 2016 at 2:22pm UTC NEW YORK–(BUSINESS WIRE)– Sidley Austin LLP announced today that Heidi Levine has joined as a partner and member of the firm’s Products Liability practice. With...
View Article